miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

BACKGROUND: Aberrant expression of microRNAs (miR) has been proposed as non-invasive biomarkers for breast cancers. The aim of this study was to analyse the miR-622 level in the plasma and in tissues of breast cancer patients and to explore the role of miR-622 and its target, the NUAK1 kinase, in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Orlandella, Francesca Maria, Mariniello, Raffaela Mariarosaria, Mirabelli, Peppino, De Stefano, Anna Elisa, Iervolino, Paola Lucia Chiara, Lasorsa, Vito Alessandro, Capasso, Mario, Giannatiempo, Rosa, Rongo, Maria, Incoronato, Mariarosaria, Messina, Francesco, Salvatore, Marco, Soricelli, Andrea, Salvatore, Giuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403386/
https://www.ncbi.nlm.nih.gov/pubmed/32418991
http://dx.doi.org/10.1038/s41416-020-0884-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403386/
https://www.ncbi.nlm.nih.gov/pubmed/32418991
http://dx.doi.org/10.1038/s41416-020-0884-9

Ejemplares similares